In the Media

New Liquid Biopsy Offers Breakthrough in Colorectal Cancer Recurrence Monitoring
USA Today Media Planet Insert
December 21, 2017

Lawrence LaPointe, CEO of Clinical Genomics Interviewed by QIAGEN 
ASCO 2017
June 4, 2017

Clinical Genomics Planning Wider Launch of Colvera After Piloting in Local Markets
May 12, 2017

Applying Advancements in Clinical Genomics to Reduce Costs
Managed Health Care Connect
April 18, 2017

Clinical Genomics Launches Colvera 
February 9, 2017

Emerging Tumor-Derived DNA Tests to Improve Colorectal Cancer Screening and Post-Treatment Monitoring for Recurrence
Physician’s Weekly
February 9, 2017

Clinical Genomics Develops Blood Test for Colorectal Cancer Recurrence Detection
Bioscience Technology
February 1, 2017

Twice the power for two-gene test
January 11, 2017

Bridgewater Center of Excellence tenant expanding its laboratory space
January 5, 2017

Clinical Genomics launches blood test for monitoring colorectal cancer recurrence
Healio Gastroenterology
January 3, 2017

How to Teach Old Dogs New Tricks with ctDNA
December 23, 2016

Clinical Genomics Launches Blood-based Colorectal Cancer test: 5 Things to Know
Becker’s GI & Endoscopy
December 21, 2016

Clinical Genomics Launches Blood-based Test for CRC Recurrence Monitoring
Medical Devices Business Review
December 21, 2016

Clinical Genomics Appoints President, IVD
December 21, 2016

A new leader at Clinical Genomics
Drug Discovery News
December 19, 2016

Blood Test Exhibits Sensitivity for Monitoring Colorectal Cancer Recurrence
Clinical Lab Products
November 8, 2016

Clinical Genomics’ circulating tumor DNA blood test proves effective for CRC recurrence detection: 3 notes
Becker’s GI & Endoscopy
November 8, 2016

New Blood Test for Colorectal Cancer Recurrence Is Twice as Sensitive as CEA Test
The ASCO Post
October 26, 2016

Colorectal Cancer Monitoring
Advance for Administrators of the Laboratory
September 2016

Clinical Genomics secures $15 million to commercialize colorectal cancer blood test
Healio Gastroenterology
March 31, 2016

Clinical Genomics closed $15M financing round for colorectal cancer recurrence blood test: 4 points
Becker’s GI & Endoscopy
March 24, 2016

Clinical Genomics brings home $15M for two-gene colorectal cancer test
March 23, 2016

Clinical Genomics Announces Closing of $15M Series A Financing Round
New Jersey Business
March 23, 2016

Clinical Genomics Closes $15M Series A Financing
March 23, 2016

Clinical Genomics Raises $15M in Series A Financing Round
Mar 22, 2016

Central Jersey pharma, biotech news 
February 11, 2016

Clinical Genomics Presents Validation Data for Blood-Based Post-Surgical CRC Recurrence Test
January 28, 2016

Positive result for new DNA blood test for bowel cancer
Medical Xpress
May 5, 2014